EUSOMA quality indicators for non-metastatic breast cancer : An update
Copyright © 2024. Published by Elsevier Ltd..
INTRODUCTION: Quality care in breast cancer is higher if patients are treated in a Breast Center with a dedicated and specialized multidisciplinary team. Quality control is an essential activity to ensure quality care, which has to be based on the monitoring of specific quality indicators. Eusoma has proceeded with the up-dating of the 2017 Quality indicators for non-metastatic breast cancer based on the new diagnostic, locoregional and systemic treatment modalities.
METHODS: To proceed with the updating, EUSOMA setup a multidisciplinary working group of BC experts and patients' representatives. It is a comprehensive set of QIs for early breast cancer care, which are classified as mandatory, recommended, or observational. For the first time patient reported outcomes (PROMs) have been included. As used in the 2017 EUSOMA QIs, evidence levels were based on the short version of the US Agency for Healthcare Research and Quality.
RESULTS: This is a set of quality indicators representative for the different steps of the patient pathway in non-metastatic setting, which allow Breast Centres to monitor their performance with referring standards, i.e minimum standard and target.
CONCLUSIONS: Monitoring these Quality Indicators, within the Eusoma datacentre will allow to have a state of the art picture at European Breast Centres level and the development of challenging research projects.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:198 |
|---|---|
| Enthalten in: |
European journal of cancer (Oxford, England : 1990) - 198(2024) vom: 01. Feb., Seite 113500 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Rubio, Isabel T [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Breast cancer care |
|---|
| Anmerkungen: |
Date Completed 05.02.2024 Date Revised 05.02.2024 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.ejca.2023.113500 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM366897357 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM366897357 | ||
| 003 | DE-627 | ||
| 005 | 20240205232028.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240114s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.ejca.2023.113500 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1281.xml |
| 035 | |a (DE-627)NLM366897357 | ||
| 035 | |a (NLM)38199146 | ||
| 035 | |a (PII)S0959-8049(23)00802-X | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Rubio, Isabel T |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a EUSOMA quality indicators for non-metastatic breast cancer |b An update |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 05.02.2024 | ||
| 500 | |a Date Revised 05.02.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright © 2024. Published by Elsevier Ltd. | ||
| 520 | |a INTRODUCTION: Quality care in breast cancer is higher if patients are treated in a Breast Center with a dedicated and specialized multidisciplinary team. Quality control is an essential activity to ensure quality care, which has to be based on the monitoring of specific quality indicators. Eusoma has proceeded with the up-dating of the 2017 Quality indicators for non-metastatic breast cancer based on the new diagnostic, locoregional and systemic treatment modalities | ||
| 520 | |a METHODS: To proceed with the updating, EUSOMA setup a multidisciplinary working group of BC experts and patients' representatives. It is a comprehensive set of QIs for early breast cancer care, which are classified as mandatory, recommended, or observational. For the first time patient reported outcomes (PROMs) have been included. As used in the 2017 EUSOMA QIs, evidence levels were based on the short version of the US Agency for Healthcare Research and Quality | ||
| 520 | |a RESULTS: This is a set of quality indicators representative for the different steps of the patient pathway in non-metastatic setting, which allow Breast Centres to monitor their performance with referring standards, i.e minimum standard and target | ||
| 520 | |a CONCLUSIONS: Monitoring these Quality Indicators, within the Eusoma datacentre will allow to have a state of the art picture at European Breast Centres level and the development of challenging research projects | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Breast cancer care | |
| 650 | 4 | |a Quality control | |
| 650 | 4 | |a Quality indicators | |
| 700 | 1 | |a Marotti, Lorenza |e verfasserin |4 aut | |
| 700 | 1 | |a Biganzoli, Laura |e verfasserin |4 aut | |
| 700 | 1 | |a Aristei, Cynthia |e verfasserin |4 aut | |
| 700 | 1 | |a Athanasiou, Alexandra |e verfasserin |4 aut | |
| 700 | 1 | |a Campbell, Christine |e verfasserin |4 aut | |
| 700 | 1 | |a Cardoso, Fatima |e verfasserin |4 aut | |
| 700 | 1 | |a Cardoso, Maria Joao |e verfasserin |4 aut | |
| 700 | 1 | |a Coles, Charlotte E |e verfasserin |4 aut | |
| 700 | 1 | |a Eicher, Manuela |e verfasserin |4 aut | |
| 700 | 1 | |a Harbeck, Nadia |e verfasserin |4 aut | |
| 700 | 1 | |a Karakatsanis, Andreas |e verfasserin |4 aut | |
| 700 | 1 | |a Offersen, Birgitte V |e verfasserin |4 aut | |
| 700 | 1 | |a Pijnappel, Ruud |e verfasserin |4 aut | |
| 700 | 1 | |a Ponti, Antonio |e verfasserin |4 aut | |
| 700 | 1 | |a Regitnig, Peter |e verfasserin |4 aut | |
| 700 | 1 | |a Santini, Donatella |e verfasserin |4 aut | |
| 700 | 1 | |a Sardanelli, Francesco |e verfasserin |4 aut | |
| 700 | 1 | |a Spanic, Tanja |e verfasserin |4 aut | |
| 700 | 1 | |a Varga, Zsuzsanna |e verfasserin |4 aut | |
| 700 | 1 | |a Vrancken Peeters, Marie Jeanne T F D |e verfasserin |4 aut | |
| 700 | 1 | |a Wengström, Yvonne |e verfasserin |4 aut | |
| 700 | 1 | |a Wyld, Lynda |e verfasserin |4 aut | |
| 700 | 1 | |a Curigliano, Giuseppe |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t European journal of cancer (Oxford, England : 1990) |d 1991 |g 198(2024) vom: 01. Feb., Seite 113500 |w (DE-627)NLM012602779 |x 1879-0852 |7 nnns |
| 773 | 1 | 8 | |g volume:198 |g year:2024 |g day:01 |g month:02 |g pages:113500 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.ejca.2023.113500 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 198 |j 2024 |b 01 |c 02 |h 113500 | ||